<DOC>
	<DOCNO>NCT01692093</DOCNO>
	<brief_summary>The purpose study determine clinical efficacy safety KM110329 Atopic dermatitis .</brief_summary>
	<brief_title>KM110329 Adult Patients With Atopic Dermatitis</brief_title>
	<detailed_description>A randomized , double blind , placebo-controlled , multicenter trial conduct Seoul St.Mary 's Hospital , Chung-ang University hospital , Kyung Hee University Hospital Gangdong . Participants fulfil eligibility criterion select . Enrolled participant randomly allocate two parallel group : KM110329 placebo arm . Each participant examine sign symptom Atopic dermatitis take functional food .</detailed_description>
	<mesh_term>Dermatitis</mesh_term>
	<mesh_term>Dermatitis , Atopic</mesh_term>
	<mesh_term>Eczema</mesh_term>
	<criteria>Men woman age 18 65 year Individuals diagnose Atopic dermatitis accord criterion Hanifin Rajka Individuals mild moderate atopic dermatitis ( objective SCORADâ‰¤40 ) Written informed consent participation trial Severe skin disease Atopic dermatitis Secondary infection bacteria , fungi , virus Uncontrolled hypertension ( SBP &gt; 145 mmHg DBP &gt; 95 mmHg ) Severe liver disability ( 2.5fold normal high range value ALT , AST ) Severe renal disability ( sCr &gt; 2.0mg/dl ) Women pregnant , lactating , plan pregnancy woman childbearing age agree proper contraception Use oral steroid , oral antibiotic immunosuppressant within past 4 week Treated systemic photochemotherapy within past 4 week History drug abuse Hypersensitivity Rubi Fructus , Houttuyniae Herba , Rehmanniae Radix , Betulae Platyphyllae Cortex Use investigational product within past two month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2013</verification_date>
	<keyword>SCORAD</keyword>
	<keyword>Atopic dermatits</keyword>
	<keyword>Skin health</keyword>
</DOC>